Timothy P. Noyes, CHIEF EXECUTIVE OFFICER at Aerovate Therapeutics, Inc. (AVTE), sold 28,950 shares at $22.71 ($687K) on 2023-03-01, disclosed to the SEC on 2023-03-03.
Open-market sale of $687k AVTE by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.71 | 5,962 | $135K | 19.7% |
| 2 | $22.71 | 5,962 | $135K | 19.7% |
| 3 | $23.81 | 2,672 | $64K | 9.3% |
| 4 | $23.81 | 2,672 | $64K | 9.3% |
| 5 | $24.69 | 5,316 | $131K | 19.1% |
| 6 | $24.69 | 5,316 |
| $131K |
| 19.1% |
| 7 | $25.67 | 1,050 | $27K | 3.9% |
| Total | $23.75 avg | 28,950 | $687K | 100% |
| Filing → |
| AVTE | SELL | 2024-04-18 | $494K | — | Filing → |
| AVTE | SELL | 2024-04-03 | $519K | — | Filing → |
| AVTE | SELL | 2023-11-03 | $11K | — | Filing → |